Candriam Equities L Biotech.I EUR Acc/ LU1120766032 /
| NAV22/01/2025 | Var.+1.1101 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 2,346.7500EUR | +0.05% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | - | - | - | -11.00 | 9.00 | 8.02 | -2.36 | - |
| 2016 | -22.88 | -4.93 | -1.29 | 3.06 | 8.39 | -8.04 | 11.86 | -2.02 | 2.94 | -10.16 | 12.33 | -2.27 | -17.28% |
| 2017 | 2.99 | 8.66 | -0.73 | -0.63 | -6.06 | 7.75 | -0.77 | 5.59 | 1.39 | -4.99 | -2.01 | 0.83 | +11.43% |
| 2018 | 2.97 | -2.64 | -2.70 | -1.36 | 8.35 | 0.97 | 4.46 | 4.80 | -1.85 | -11.78 | 4.28 | -9.24 | -5.57% |
| 2019 | 12.84 | 4.24 | 0.92 | -4.67 | -4.18 | 7.07 | -0.09 | -1.27 | -3.22 | 7.98 | 13.15 | 0.65 | +36.28% |
| 2020 | -3.94 | -0.26 | -4.88 | 13.11 | 7.67 | 0.44 | -7.71 | -0.21 | 2.72 | -2.15 | 6.96 | 0.76 | +11.20% |
| 2021 | 2.61 | -2.43 | -1.06 | 0.36 | -3.34 | 9.33 | -1.38 | 4.46 | -2.39 | 0.38 | -1.61 | 1.44 | +5.86% |
| 2022 | -9.49 | -2.17 | 6.73 | -2.56 | -4.79 | 5.58 | 7.26 | 2.53 | 0.67 | 6.00 | 1.92 | -6.17 | +3.88% |
| 2023 | 1.21 | -3.40 | -1.97 | 0.66 | 2.31 | -1.05 | -1.18 | 1.42 | -1.89 | -5.97 | 2.68 | 12.11 | +3.96% |
| 2024 | 3.05 | 1.74 | 0.26 | -5.18 | 2.58 | 6.76 | 5.43 | -0.64 | -3.10 | 1.11 | 3.22 | -5.09 | - |
| 2025 | 0.36 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 19.39% | 19.31% | 17.82% | 20.38% | 23.27% |
| Indice di Sharpe | 0.18 | -0.48 | 0.23 | 0.39 | 0.17 |
| Mese migliore | +0.36% | +5.43% | +6.76% | +12.11% | +13.11% |
| Mese peggiore | -5.09% | -5.09% | -5.18% | -9.49% | -9.49% |
| Perdita massima | -3.79% | -10.92% | -10.92% | -17.58% | -26.96% |
| Outperformance | -3.12% | - | -0.76% | - | - |
Tutte le quotazioni in EUR
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,073.4700 | +0.30% | +15.54% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,346.7500 | +6.72% | +35.12% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,570.7800 | +5.46% | +35.89% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,889.6700 | +2.78% | +28.71% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 232.5600 | +6.13% | +34.99% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 376.8300 | +5.85% | +39.64% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 345.2500 | +7.11% | +38.66% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 199.6900 | -1.87% | +12.51% | |
| Candriam Equities L Biotechnolog... | reinvestment | 149.7300 | -1.32% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,736.9600 | +2.18% | +24.48% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,098.2500 | +2.28% | +25.02% | |
| Candriam Equities L Biotech.N US... | reinvestment | 608.3000 | +1.26% | +23.09% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 198.2500 | -0.20% | +15.57% | |
| Candriam Equities L Biotech.R US... | reinvestment | 273.5000 | +2.55% | +27.77% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 207.9000 | +0.64% | +18.50% | |
| Candriam Equities L Biotechnolog... | reinvestment | 855.9900 | +1.64% | +24.56% | |
| Candriam Equities L Biotechnolog... | paying dividend | 781.6000 | +1.61% | +24.44% |
Prestazione
| YTD | +0.36% | ||
|---|---|---|---|
| 6 mesi | -3.36% | ||
| 1 anno | +6.72% | ||
| 3 anni | +35.12% | ||
| 5 anni | +38.36% | ||
| Dall'inizio | +56.45% | ||
| Anno | |||
| 2023 | +3.96% | ||
| 2022 | +3.88% | ||
| 2021 | +5.86% | ||
| 2020 | +11.20% | ||
| 2019 | +36.28% | ||
| 2018 | -5.57% | ||
| 2017 | +11.43% | ||
| 2016 | -17.28% | ||